Nova’s influenza model accounts for the interplay between a viral infection and vaccination. It describes the key pathways and biomarkers influencing vaccine efficacy, including antigenic drift, strain, immunogenicity, immunosenescence and timing of vaccination.
Model description (Influenza)
Drugs that can be tested
Populations of interest
Possible clinical endpoints
Early insights to optimize your trial design
Get your questions answered by downloading the free pdf and learn more about your therapeutic area of interest!